Stocktoria
PDS Biotechnology Corp PDSB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-10-01
PDS Biotechnology Corp statistics & valuation
Market cap$49.6M
P / B5.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -113.1% | -82.9% | -72.3% | -53.1% | -25.2% |
| Return on equity | -372.9% | -197.9% | -164.3% | -92.8% | -26.8% |
| Current ratio | 2.98 | 2.64 | 4.33 | 7.79 | 17.80 |
Source: SEC EDGAR filings · CIK 0001472091 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.